Importance of early use of tolvaptan in hyponatremic acutely decompensated heart failure patients, a retrospective study
Abstract Background Hyponatremia is one of the complicating findings in acute decompensated heart failure. Decrease in cardiac output and systemic blood pressure triggers activation of renin–angiotensin–aldosterone system, antidiuretic hormone, and norepinephrine due to the perceived hypovolemia. Fl...
Saved in:
| Main Authors: | Rarsari Soerarso, Emir Yonas, Silfi Pauline Sirait, Dian Yaniarti Hasanah, Sunu Budhi Raharjo, Bambang Budi Siswanto, Maarten J. Cramer, Pim van der Harst, Marish I. F. J. Oerlemans |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-01-01
|
| Series: | The Egyptian Heart Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43044-024-00603-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe tolvaptan-associated hyperglycemia: a case report
by: Huihuan Sun, et al.
Published: (2025-07-01) -
Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in Thailand
by: Permsuwan U, et al.
Published: (2025-07-01) -
Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction
by: Shunsuke Tamaki, et al.
Published: (2020-06-01) -
Kidney Function Trajectories with Tolvaptan in ADPKD Patients with CKD-G5
by: Akinari Sekine, et al.
Published: (2025-06-01) -
Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update
by: Matt Gittus, et al.
Published: (2025-02-01)